Drug:
Reaction: GAIT DISTURBANCE
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940371 |
JP |
72 | 1 |
Cerebellar syndrome, Toxicity to various agents, Gait disturbance, Dyslalia, Nystagmus, |
||||
CAPECITABINE, PHENYTOIN, OXALIPLATIN, PHENOBARBITAL, |
||||
| 2 | 26940479 |
US |
2 | |
Bone pain, Gait disturbance, Weight increased, Pain in extremity, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 3 | 26940594 |
US |
77 | 2 |
Paraesthesia, Gait disturbance, Headache, Muscle spasms, Diarrhoea, Vomiting, |
||||
ABALOPARATIDE, ERGOCALCIFEROL, |
||||
| 4 | 26940711 |
US |
2 | |
Gait disturbance, Myalgia, Muscular weakness, Heart rate decreased, Feeling abnormal, Headache, Fatigue, Palpitations, Muscle spasms, Nausea, Intentional product misuse, |
||||
ABALOPARATIDE, ABALOPARATIDE, LOSARTAN POTASSIUM, |
||||
| 5 | 26940910 |
US |
2 | |
Myalgia, Post polio syndrome, Gait disturbance, Arthralgia, Pain, Back pain, Bone pain, Pain in extremity, Muscle spasms, |
||||
ABALOPARATIDE, DULOXETINE HYDROCHLORIDE, |
||||
| 6 | 26940913 |
US |
74 | 2 |
Joint stiffness, Gait disturbance, Unevaluable event, Neck pain, Nausea, Diarrhoea, Fatigue, Malaise, Heart rate increased, Headache, Blood calcium increased, Device use issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 7 | 26940947 |
US |
1 | |
Mobility decreased, Gait disturbance, Feeling abnormal, Blood parathyroid hormone decreased, Pain, Asthenia, Nausea, |
||||
ABALOPARATIDE, |
||||
| 8 | 26940962 |
US |
2 | |
Gait disturbance, Muscle spasms, Rash, |
||||
ABALOPARATIDE, AZELASTINE HYDROCHLORIDE, AZELASTINE, CICLOPIROX, FLUTICASONE PROPIONATE, |
||||
| 9 | 26941060 |
US |
2 | |
Drug intolerance, Gait disturbance, Dyspnoea, Pain in extremity, Arthralgia, Fatigue, Bone pain, Headache, Product use issue, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 10 | 26941178 |
US |
2 | |
Pyrexia, Rhinorrhoea, Cough, Gait disturbance, Meniscus injury, Nasal congestion, Osteoarthritis, Arthralgia, Diarrhoea, Headache, Pain, Fatigue, |
||||
ABALOPARATIDE, |
||||
| 11 | 26941326 |
US |
36 | 2 |
Weight bearing difficulty, Gait disturbance, Injection site pain, Injection site swelling, Injection site bruising, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 12 | 26941430 |
US |
70 | 2 |
Coma, Intestinal perforation, Liver transplant, Cardiac disorder, Gait disturbance, Chest pain, Hepatic steatosis, Therapy interrupted, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, |
||||
| 13 | 26941487 |
US |
2 | |
Gait disturbance, Peripheral swelling, Skin discolouration, Rash macular, Back pain, |
||||
ABALOPARATIDE, |
||||
| 14 | 26941503 |
US |
65 | 1 |
Suicidal ideation, Depression, Anxiety, Agitation, Restlessness, Asthenia, Panic attack, Insomnia, Aggression, Anger, Mood altered, Abnormal behaviour, Pain, Joint swelling, Fatigue, Confusional state, Amnesia, Somnolence, Headache, Gait disturbance, Coordination abnormal, Tinnitus, Increased appetite, Weight increased, Abdominal pain upper, Fall, Chills, Condition aggravated, Rapid eye movement sleep behaviour disorder, |
||||
DIVALPROEX SODIUM, DIVALPROEX SODIUM, |
||||
| 15 | 26941561 |
US |
2 | |
Gait disturbance, Weight increased, Arthralgia, Pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 16 | 26941915 |
US |
2 | |
Gait disturbance, Balance disorder, Cardiac disorder, Muscular weakness, Illness, Blood calcium increased, Malaise, Nausea, Fatigue, Pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, SODIUM POLYSTYRENE SULFONATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ACETAMINOPHEN, HEPARIN SODIUM, ERGOCALCIFEROL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DANAZOL, FLUCONAZOLE, CHLOROQUINE PHOSPHATE, |
||||
| 17 | 26941925 |
US |
2 | |
Hypoaesthesia, Gait disturbance, Arthralgia, Pain in extremity, |
||||
ABALOPARATIDE, |
||||
| 18 | 26942065 |
US |
74 | 1 |
Generalised tonic-clonic seizure, On and off phenomenon, Gait disturbance, Illness, Condition aggravated, Therapeutic response shortened, Urinary tract infection, Asthenia, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 19 | 26942072 |
US |
78 | 2 |
Cataract, Gait disturbance, Visual impairment, |
||||
LINACLOTIDE, |
||||
| 20 | 26942074 |
EU |
74 | 2 |
Hypokinesia, Hallucination, On and off phenomenon, Movement disorder, Pain in extremity, Gait disturbance, Therapeutic product effect incomplete, Mobility decreased, Limb discomfort, Malaise, General physical health deterioration, Emotional disorder, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, PREGABALIN, QUETIAPINE, FOLIC ACID, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, BISOPROLOL FUMARATE, CANDESARTAN, RIVAROXABAN, |
||||
| 21 | 26942163 |
US |
49 | 2 |
Eye pain, Gait disturbance, Arthralgia, Sinuplasty, |
||||
DUPILUMAB, |
||||
| 22 | 26942212 |
US |
62 | 2 |
Hip fracture, Multiple sclerosis, Device malfunction, Fall, Gait disturbance, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
| 23 | 26942725 |
US |
1 | |
Fall, Contusion, Gait disturbance, |
||||
RISDIPLAM, |
||||
| 24 | 26943112 |
CA |
44 | 2 |
Breast cancer stage III, Folliculitis, Sciatica, Hypoaesthesia, Memory impairment, Dyspepsia, Taste disorder, Crohn^s disease, Bone erosion, Gait inability, Gastrooesophageal reflux disease, Pneumonia, Decreased appetite, Insomnia, Disability, Confusional state, Grip strength decreased, Sleep disorder due to a general medical condition, Product use in unapproved indication, Blister, Adjustment disorder with depressed mood, Dislocation of vertebra, Hypercholesterolaemia, Lip dry, Blepharospasm, Systemic lupus erythematosus, Therapeutic product effect decreased, Anxiety, Delirium, Impaired healing, Infusion site reaction, Malaise, Bursitis, Facet joint syndrome, Lower respiratory tract infection, Dyspnoea, Drug intolerance, Prescribed overdose, Helicobacter infection, Dizziness, Sleep disorder, Rash, Glossodynia, C-reactive protein increased, Ulcer haemorrhage, Incorrect route of product administration, Therapeutic product effect incomplete, Maternal exposure during pregnancy, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Respiratory disorder, Psoriatic arthropathy, Urticaria, Depression, Contusion, Hepatic cirrhosis, Product quality issue, Hypersensitivity, Blood cholesterol increased, Drug hypersensitivity, Sinusitis, Exostosis, Discomfort, Deep vein thrombosis postoperative, Intentional product use issue, Condition aggravated, Diarrhoea, Hand deformity, Gait disturbance, Lower limb fracture, X-ray abnormal, Pericarditis, Stomatitis, Back injury, Duodenal ulcer perforation, Lupus-like syndrome, Ear pain, Ill-defined disorder, Alopecia, Fatigue, Synovitis, Type 2 diabetes mellitus, Prescribed underdose, Exposure during pregnancy, Rheumatoid factor positive, Product use issue, Epilepsy, Rheumatoid arthritis, Gastrointestinal disorder, Swollen joint count increased, Red blood cell sedimentation rate increased, Treatment failure, Irritable bowel syndrome, Contraindicated product administered, Swelling, Hypertension, Breast cancer stage II, Laryngitis, Drug ineffective, Pyrexia, Asthenia, Headache, Medication error, General physical health deterioration, Asthma, Therapy non-responder, Hepatic enzyme increased, Chest pain, Rheumatic fever, Drug tolerance, Fibromyalgia, Dry mouth, Peripheral swelling, Infusion related reaction, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, INFLIXIMAB, ABATACEPT, OXYCODONE, OXYCODONE, CELECOXIB, CELECOXIB, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, PREDNISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, SECUKINUMAB, MEPOLIZUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CELECOXIB, CELECOXIB, RAMIPRIL, RAMIPRIL, LAMOTRIGINE, LAMOTRIGINE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, PREDNISONE, |
||||
| 25 | 26943252 |
US |
60 | 2 |
Myalgia, Muscular weakness, Gait disturbance, Rash, Arthralgia, |
||||
DUPILUMAB, |
||||
| 26 | 26943398 |
41 | 2 | |
Tendon rupture, Greater trochanteric pain syndrome, Tendon disorder, Arthralgia, Gait disturbance, General physical health deterioration, |
||||
CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, |
||||
| 27 | 26943512 |
US |
20 | 2 |
Arthralgia, Fatigue, Contusion, Gait disturbance, |
||||
ELOSULFASE ALFA, |
||||
| 28 | 26944034 |
CL |
62 | 2 |
Blood pressure increased, Feeling abnormal, Fall, Epilepsy, Anxiety, Ankle fracture, Migraine, Hypertension, Bradycardia, Hypotension, Amnesia, Blood creatinine increased, Diarrhoea, Nausea, Vomiting, Blood alkaline phosphatase increased, C-reactive protein abnormal, Blood urea abnormal, Blood cholesterol abnormal, Foot fracture, International normalised ratio abnormal, Blood potassium abnormal, Insomnia, Dizziness, White blood cell count decreased, Haematocrit decreased, Haemoglobin decreased, Depression, Skin discolouration, Malaise, Emotional distress, Headache, Abnormal behaviour, Ligament sprain, Myopia, Colitis, Contusion, Wound, Pain, Keratitis, Thrombosis, Metastases to bone, Loss of consciousness, Petit mal epilepsy, Choking, Asphyxia, Sarcoma, Metastases to lung, Neutrophil count decreased, Tinnitus, Immunodeficiency, Eye swelling, Pulmonary pain, Nasal ulcer, Noninfective gingivitis, Gingival erythema, Aphthous ulcer, Weight increased, Morton^s neuralgia, Hypoglycaemia, Food intolerance, Scab, Epistaxis, Nasal injury, Gait disturbance, Ageusia, Visual impairment, Musculoskeletal chest pain, General physical health deterioration, Influenza, Productive cough, Cough, Pharyngitis, Haemoptysis, Electric shock sensation, Full blood count decreased, Fat tissue increased, Fluid retention, Pain, Dry eye, Back pain, Fatigue, Dysgeusia, Abdominal discomfort, Diarrhoea, Headache, Depressed mood, Memory impairment, Weight decreased, Blood sodium increased, Aversion, Eye pain, Yawning, Eyelid margin crusting, Eye disorder, Swelling, Gastrointestinal disorder, Nervousness, Anisocytosis, Poikilocytosis, Polychromasia, Macrocytosis, Red cell distribution width increased, Elliptocytosis, Atrioventricular block first degree, Discomfort, Mean cell volume increased, Blood glucose increased, Rouleaux formation, Red blood cell sedimentation rate increased, Limb deformity, Oral herpes, Ill-defined disorder, Arthritis, Hypersensitivity, Pruritus, Pyrexia, Dry skin, Lymphocyte count decreased, Red blood cell count decreased, Decreased immune responsiveness, Thyroid mass, Visual impairment, Neoplasm, Gingival disorder, Pain in extremity, Vision blurred, Chills, Herpes virus infection, Agitation, Confusional state, Catheter site pain, Gastrooesophageal reflux disease, Oesophagitis, Stress, High density lipoprotein abnormal, Gait inability, Mobility decreased, Diplopia, Impaired healing, Viral diarrhoea, Nasopharyngitis, Alopecia, Tension headache, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LANSOPRAZOLE, CALCIUM, MORPHINE, |
||||
| 29 | 26944820 |
US |
2 | |
Blood pressure abnormal, Gait disturbance, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 30 | 26944840 |
US |
2 | |
Migraine, Gait disturbance, Nausea, Back pain, Injection site haemorrhage, Dizziness, |
||||
ABALOPARATIDE, |
||||
| 31 | 26944888 |
US |
74 | 2 |
Blood pressure decreased, Gait disturbance, Dizziness, Bone pain, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 32 | 26944944 |
US |
2 | |
Eyelids pruritus, Gait disturbance, Joint stiffness, Musculoskeletal stiffness, Dermal cyst, Dizziness, Injection site bruising, Fatigue, Hypersensitivity, |
||||
ABALOPARATIDE, |
||||
| 33 | 26944991 |
US |
39 | 1 |
Tremor, Drug ineffective, Balance disorder, Gait disturbance, |
||||
GLATIRAMER ACETATE, |
||||
| 34 | 26945014 |
US |
2 | |
Gait disturbance, Fatigue, Nausea, Vomiting, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 35 | 26945142 |
US |
2 | |
Chest discomfort, Dysstasia, Gait disturbance, Blood iron decreased, Nausea, |
||||
ABALOPARATIDE, BIOTIN, CELECOXIB, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FERROUS SULFATE, GABAPENTIN, ROPINIROLE, LEVOTHYROXINE SODIUM, CYANOCOBALAMIN, |
||||
| 36 | 26945712 |
CA |
62 | 2 |
Loss of personal independence in daily activities, Therapeutic product effect incomplete, Drug dependence, Dyspnoea, Lung adenocarcinoma stage IV, Steroid dependence, Chest discomfort, Malaise, Sleep disorder due to a general medical condition, Illness, Exercise tolerance decreased, Metastases to central nervous system, Pneumothorax, Wheezing, Chronic obstructive pulmonary disease, Bronchitis, Bone pain, Seizure, Heart rate increased, Asthma, Full blood count abnormal, Joint swelling, Gait disturbance, |
||||
PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, ERGOCALCIFEROL, ERGOCALCIFEROL, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, MEPOLIZUMAB, RISEDRONATE SODIUM, RISEDRONATE SODIUM, ALBUTEROL SULFATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ALBUTEROL SULFATE, ALBUTEROL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
| 37 | 26945784 |
US |
2 | |
Blood pressure decreased, Gait disturbance, Headache, Pain, Heart rate increased, Fatigue, Arthralgia, |
||||
ABALOPARATIDE, ERGOCALCIFEROL, |
||||
| 38 | 26945858 |
CA |
57 | 2 |
Loss of consciousness, Neuralgia, Dermatitis, Skin lesion, Pain, Skin burning sensation, Pain in extremity, Mobility decreased, Gait disturbance, Condition aggravated, Rash, Dermatitis atopic, Blister, Pain, Skin fissures, Peripheral swelling, Skin hypertrophy, Electric shock sensation, |
||||
DUPILUMAB, DUPILUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, AMLODIPINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, |
||||
| 39 | 26945953 |
US |
2 | |
Gait disturbance, Arthritis, Arthralgia, Pain, Insomnia, |
||||
ABALOPARATIDE, CERTOLIZUMAB PEGOL, |
||||
| 40 | 26946079 |
US |
74 | 2 |
Nocturia, Balance disorder, Memory impairment, Depressed mood, Disturbance in attention, Vertigo, Fatigue, Dizziness, Insomnia, Headache, Nausea, Palpitations, Gait disturbance, |
||||
ABALOPARATIDE, GABAPENTIN, |
||||
| 41 | 26946114 |
US |
69 | 2 |
Gait disturbance, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 42 | 26946340 |
US |
2 | |
Crepitations, Muscular weakness, Neck pain, Gait disturbance, Dysstasia, Anger, Headache, Palpitations, Bone pain, Fatigue, Abdominal distension, Arthralgia, Back pain, |
||||
ABALOPARATIDE, |
||||
| 43 | 26946375 |
US |
65 | 2 |
Dry mouth, Weight increased, Hiatus hernia, Gastrooesophageal reflux disease, Osteoporosis, Intervertebral disc degeneration, Condition aggravated, Gait disturbance, Vitamin D decreased, Blood sodium decreased, Blood potassium increased, Thyroid disorder, Alopecia, Nocturia, Blood chloride decreased, White blood cells urine positive, White blood cell count abnormal, Nervousness, Productive cough, Dizziness, Contusion, Muscle spasms, Abdominal distension, Pain in extremity, Palpitations, Fatigue, Bone pain, |
||||
ABALOPARATIDE, FAMOTIDINE, |
||||
| 44 | 26946376 |
US |
2 | |
Gait disturbance, Feeling abnormal, Drug interaction, Product use in unapproved indication, |
||||
ABALOPARATIDE, CYCLOBENZAPRINE, FLUTICASONE PROPIONATE, GABAPENTIN, INSULIN LISPRO, IRON, EMPAGLIFLOZIN, LISINOPRIL, MAGNESIUM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, OXYCODONE HYDROCHLORIDE, OXYCODONE, ORAL SEMAGLUTIDE, POTASSIUM CARBONATE, |
||||
| 45 | 26946400 |
US |
77 | 2 |
Hospitalisation, Gait disturbance, Therapy interrupted, Product use issue, |
||||
ABALOPARATIDE, |
||||
| 46 | 26946433 |
US |
2 | |
Intervertebral disc disorder, Spinal disorder, Gait disturbance, Back pain, |
||||
ABALOPARATIDE, |
||||
| 47 | 26946463 |
US |
2 | |
Adverse drug reaction, Oxygen saturation decreased, Chest pain, Gait disturbance, Abdominal discomfort, Nausea, Headache, Fatigue, Palpitations, Heart rate increased, Bone pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FOLIC ACID, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE, FISH OIL, CALCIUM, DICYCLOMINE HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
| 48 | 26946526 |
US |
63 | 2 |
Gait disturbance, Back pain, Pain in extremity, |
||||
ABALOPARATIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, ERGOCALCIFEROL, CYCLOSPORINE, HYDROXYCHLOROQUINE SULFATE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 49 | 26946643 |
US |
2 | |
Gait disturbance, Bone pain, Arthralgia, Off label use, |
||||
ABALOPARATIDE, |
||||
| 50 | 26946695 |
US |
1 | |
Gait disturbance, Swelling, Pain in extremity, Asthenia, Muscle spasms, Pain, Drug ineffective, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 51 | 26946761 |
US |
2 | |
Gait disturbance, Muscle spasms, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, DENOSUMAB, |
||||
| 52 | 26946778 |
US |
1 | |
Radiotherapy, Dysuria, Chills, Gait disturbance, Back pain, Dizziness, Fatigue, Abdominal pain upper, Malaise, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, DIPHENHYDRAMINE HYDROCHLORIDE, FISH OIL, VITAMIN E, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, CETIRIZINE HYDROCHLORIDE, MOMETASONE, CALCIUM, |
||||
| 53 | 26946788 |
US |
2 | |
Surgery, Discomfort, Gait disturbance, Back pain, |
||||
ABALOPARATIDE, CALCIUM, ERGOCALCIFEROL, |
||||
| 54 | 26946898 |
US |
2 | |
Spinal pain, Spinal pain, Gait disturbance, Dyspepsia, Feeling abnormal, Fatigue, Injection site pain, Abdominal pain upper, Incorrect dose administered, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 55 | 26947016 |
US |
2 | |
Gait disturbance, Dysstasia, Muscle spasms, |
||||
ABALOPARATIDE, |
||||
| 56 | 26947060 |
US |
2 | |
Gait disturbance, Feeling jittery, Pain, Asthenia, Palpitations, Heart rate increased, |
||||
ABALOPARATIDE, ABALOPARATIDE, GABAPENTIN, |
||||
| 57 | 26947223 |
US |
81 | 1 |
Fall, Gait disturbance, Sleep disorder, Feeling abnormal, Pain in extremity, |
||||
ABALOPARATIDE, ABALOPARATIDE, EVOLOCUMAB, PIMECROLIMUS, RUXOLITINIB, PERFLUOROHEXYLOCTANE, TOLTERODINE TARTRATE, TOLTERODINE, DONEPEZIL HYDROCHLORIDE, ESCITALOPRAM, FINASTERIDE, AMITRIPTYLINE HYDROCHLORIDE, ALLOPURINOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ESOMEPRAZOLE MAGNESIUM, PENTOSAN POLYSULFATE SODIUM, FAMOTIDINE, ERGOCALCIFEROL, FEXOFENADINE HYDROCHLORIDE, |
||||
| 58 | 26947239 |
US |
80 | 2 |
Sciatica, Gait disturbance, |
||||
ABALOPARATIDE, LATANOPROST, IRON, ALBUTEROL SULFATE, ALBUTEROL, CETIRIZINE HYDROCHLORIDE, MONTELUKAST, LISINOPRIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, NIFEDIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM, MAGNESIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, BRIMONIDINE TARTRATE, TIMOLOL MALEATE, |
||||
| 59 | 26947333 |
US |
2 | |
Gait disturbance, Injection site bruising, Cystitis, Headache, Dizziness, Abdominal distension, Blood calcium increased, Product dose omission issue, Wrong technique in device usage process, Product use in unapproved indication, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, EMPAGLIFLOZIN, MAGNESIUM, ALBUTEROL SULFATE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, METHOCARBAMOL, METHOCARBAMOL TABLETS, MONTELUKAST, PREDNISONE, CALCIUM, |
||||
| 60 | 26947344 |
US |
2 | |
Chest discomfort, Gait disturbance, Dizziness, Pain, |
||||
ABALOPARATIDE, LOSARTAN POTASSIUM, LOSARTAN, SIMVASTATIN, |
||||
| 61 | 26947349 |
CA |
43 | |
Confusional state, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Facet joint syndrome, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Liver disorder, Lower limb fracture, Lung disorder, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nausea, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Pyrexia, Rash, Rheumatoid arthritis, Rheumatoid factor positive, Sciatica, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Nasopharyngitis, Sinusitis, Wound infection, Drug intolerance, Treatment failure, Contraindicated product administered, Off label use, Product use in unapproved indication, Suspected off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, INFLIXIMAB, INFLIXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM, CALCIUM, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ADALIMUMAB-ADAZ, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREGABALIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RISEDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TOFACITINIB CITRATE, TOFACITINIB CITRATE, VITAMIN C, ERGOCALCIFEROL, ERGOCALCIFEROL, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 62 | 26947577 |
US |
2 | |
Gait disturbance, Myalgia, Back pain, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 63 | 26947700 |
US |
50 | 2 |
Chest discomfort, Chest pain, Muscle tightness, Musculoskeletal chest pain, Gait disturbance, Joint noise, Abdominal discomfort, Back pain, Arthralgia, Pain in extremity, Heart rate increased, |
||||
ABALOPARATIDE, |
||||
| 64 | 26948164 |
US |
2 | |
Retching, Gait disturbance, Palpitations, Nausea, Dizziness, Injection site pain, Injection site erythema, Injection site swelling, Headache, Heart rate increased, Fatigue, Abdominal pain upper, Vertigo, Off label use, Device use issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 65 | 26948192 |
US |
2 | |
Gait disturbance, Visual impairment, Hypoacusis, Cystitis, Diarrhoea, Fatigue, Abdominal pain upper, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 66 | 26951441 |
85 | 2 | |
Weight decreased, Fall, Asthenia, Gait disturbance, Decreased appetite, |
||||
TIRZEPATIDE, |
||||
| 67 | 26934113 |
69 | 2 | |
Drug ineffective, Dysstasia, Gait disturbance, Madarosis, Urine analysis abnormal, Nail discolouration, Nail disorder, Onychomadesis, Pain, Pain in extremity, Influenza, Micturition urgency, Pneumonia, Pollakiuria, Back pain, Insomnia, Musculoskeletal pain, Rash macular, Incorrect dose administered, |
||||
MIRTAZAPINE, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 68 | 26934311 |
US |
64 | 2 |
Feeling abnormal, Malaise, Nausea, Abdominal pain upper, Balance disorder, Fatigue, Weight increased, Hiccups, Gait disturbance, Drug hypersensitivity, Hallucination, auditory, |
||||
DIVALPROEX SODIUM, ARIPIPRAZOLE, ARIPIPRAZOLE, ASCORBIC ACID, CYANOCOBALAMIN, FERROUS SULFATE, FOLIC ACID, NICOTINAMIDE, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE, |
||||
| 69 | 26934620 |
US |
2 | |
Sluggishness, Drug ineffective, Gait disturbance, Confusional state, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 70 | 26935056 |
BR |
2 | |
Skull fracture, Haemorrhoids, Carcinoembryonic antigen increased, Liver injury, Metastasis, Metastases to bone, Metastases to liver, Metastases to spine, Metastases to thorax, Metastases to thyroid, Breast cancer metastatic, Metastases to liver, Haemorrhage, Skin fissures, Face injury, Dry throat, Dry skin, Rectocele, Nasal dryness, Vulvovaginal dryness, Skin exfoliation, Nasal discomfort, Contusion, Vascular rupture, Clavicle fracture, Panic attack, Blood oestrogen decreased, Skin disorder, Skin atrophy, Pain, Injury, Bone neoplasm, Limb injury, Peripheral swelling, Skin discolouration, Hypokinesia, Movement disorder, Limb discomfort, Muscular weakness, Lymphadenopathy, Stress, Erythema, Feeling abnormal, Gastrooesophageal reflux disease, Gait disturbance, Quality of life decreased, Rhinitis, Fatigue, Bone pain, Abdominal pain upper, PIK3CA-activated mutation, Hepatic mass, Nodule, Brain fog, Weight decreased, Insomnia, Greater trochanteric pain syndrome, Dry eye, Urinary tract infection, Arthralgia, Rash macular, Pain in extremity, Epistaxis, Alopecia, Hypersensitivity, Haematoma, Pruritus, Erythema, Tumour marker increased, Injection site swelling, Drug intolerance, Dizziness, Vomiting, Head discomfort, Malaise, Constipation, Polyp, Retching, Nausea, Dehydration, Sinusitis, Eating disorder, Thermal burn, Skin lesion, Hiatus hernia, Sensory loss, Drug ineffective, Needle issue, |
||||
FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, PANTOPRAZOLE, ANASTROZOLE, ANASTROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, ZOLEDRONIC ACID, ZOLEDRONIC ACID, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ALPELISIB, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, CLONAZEPAM, EXEMESTANE, |
||||
| 71 | 26935467 |
EU |
76 | 2 |
Gait disturbance, Myalgia, |
||||
TREMELIMUMAB, DURVALUMAB, LISINOPRIL, DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, |
||||
| 72 | 26935482 |
US |
81 | 1 |
Fatigue, Gait disturbance, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 73 | 26935598 |
EU |
70 | 1 |
Pericardial effusion, Chronic obstructive pulmonary disease, Cough, Fatigue, Blood glucose increased, Dry mouth, Thirst, Gait disturbance, Hypoglycaemia, Asthenia, |
||||
INSULIN GLARGINE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, DEFLAZACORT, METHYLPREDNISOLONE, |
||||
| 74 | 26935717 |
EU |
56 | 2 |
Dizziness, Constipation, Vomiting, Gait disturbance, |
||||
ATOGEPANT, |
||||
| 75 | 26935749 |
US |
1 | |
Renal impairment, Productive cough, Musculoskeletal disorder, Dyspnoea exertional, Musculoskeletal stiffness, Gait disturbance, Pain, Nausea, Product dose omission issue, Urinary incontinence, |
||||
ACALABRUTINIB, |
||||
| 76 | 26936614 |
CO |
78 | 2 |
Fibromyalgia, Loss of consciousness, Syncope, Spinal disorder, Arthropathy, Hypoacusis, Cardiac failure, Migraine, Bronchitis, Balance disorder, Mobility decreased, Gait disturbance, Gastrointestinal hypomotility, Dyschezia, Constipation, |
||||
DENOSUMAB, DENOSUMAB, |
||||
| 77 | 26936618 |
US |
2 | |
Brain oedema, Neuroleptic malignant syndrome, Speech disorder, Visual impairment, Blood pressure abnormal, Dysstasia, Ear disorder, Sinusitis, Parkinsonism, Thinking abnormal, Gait disturbance, Paraesthesia, Tremor, Throat tightness, Oropharyngeal swelling, Product use in unapproved indication, |
||||
ILOPERIDONE, LISINOPRIL, |
||||
| 78 | 26936631 |
CN |
54 | 1 |
Pigmentation disorder, Hypoaesthesia, Dermatitis allergic, Pain in extremity, Gait disturbance, |
||||
PEMBROLIZUMAB, CARBOPLATIN, |
||||
| 79 | 26936999 |
EU |
77 | 1 |
Neurotoxicity, Gait disturbance, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), GEMCITABINE HYDROCHLORIDE, |
||||
| 80 | 26937153 |
|||
Pain in extremity, Gait disturbance, |
||||
PANTOPRAZOLE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DAPAGLIFLOZIN, EPLERENONE, FUROSEMIDE, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 81 | 26937193 |
CN |
42 | 2 |
Palpitations, Tremor, Gait disturbance, |
||||
INCLISIRAN, |
||||
| 82 | 26937924 |
CN |
30 | 1 |
Renal function test abnormal, Dysstasia, Mental disorder, Liver function test abnormal, Electrolyte imbalance, Gastritis, Nausea, Vomiting, Asthenia, Gait disturbance, Toxicity to various agents, Depressed mood, |
||||
ZOLPIDEM TARTRATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AMANTADINE HYDROCHLORIDE, VITAMIN C, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, MANNITOL, |
||||
| 83 | 26938148 |
US |
2 | |
Gait disturbance, |
||||
INSULIN GLARGINE, |
||||
| 84 | 26938935 |
US |
85 | 2 |
Gait disturbance, Muscular weakness, Fatigue, Asthenia, Dizziness, Injection site bruising, Pain in extremity, Malaise, |
||||
ABALOPARATIDE, |
||||
| 85 | 26939021 |
US |
78 | 2 |
Gait disturbance, Fear of falling, Depressed mood, Muscular dystrophy, Fatigue, Arthralgia, Pain in extremity, |
||||
ABALOPARATIDE, |
||||
| 86 | 26939069 |
US |
2 | |
Diplopia, Gait disturbance, Headache, Product use in unapproved indication, |
||||
ABALOPARATIDE, ALBUTEROL SULFATE, BACLOFEN, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 87 | 26939095 |
US |
2 | |
Myalgia, Gait disturbance, Headache, Nausea, Insomnia, Pain, |
||||
ABALOPARATIDE, |
||||
| 88 | 26939124 |
US |
2 | |
Hyperhidrosis, Myalgia, Gait disturbance, Fatigue, Dizziness, Heart rate increased, Muscle spasms, Muscle atrophy, Pain in extremity, Gait inability, Chills, |
||||
ABALOPARATIDE, |
||||
| 89 | 26939205 |
US |
2 | |
Joint swelling, Peripheral swelling, Gait disturbance, |
||||
ABALOPARATIDE, CALCIUM, |
||||
| 90 | 26939214 |
US |
66 | 2 |
Trismus, Gait disturbance, Muscle spasms, |
||||
ABALOPARATIDE, |
||||
| 91 | 26939215 |
US |
2 | |
Rhinitis allergic, Gait disturbance, Abdominal discomfort, Dizziness, Headache, Arthralgia, Constipation, Fatigue, Bone pain, Pain, Asthenia, Insomnia, Product dose omission in error, Liquid product physical issue, |
||||
ABALOPARATIDE, |
||||
| 92 | 26939295 |
US |
73 | 2 |
Gait disturbance, Sleep disorder, Myalgia, Arthralgia, Bone pain, Drug ineffective, |
||||
ABALOPARATIDE, ROSUVASTATIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, ALLOPURINOL, FUROSEMIDE, LABETALOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, INSULIN GLARGINE, INSULIN ASPART, |
||||
| 93 | 26939363 |
US |
71 | 1 |
Groin pain, Pain, Gait disturbance, |
||||
ABALOPARATIDE, |
||||
| 94 | 26939580 |
US |
2 | |
Spinal fusion surgery, Urinary tract infection, Procedural pain, Hypoaesthesia, Burning sensation, Gait disturbance, Joint instability, Paraesthesia, Dyspepsia, Neuralgia, Back pain, Headache, Arthralgia, Fatigue, Off label use, |
||||
ABALOPARATIDE, |
||||
| 95 | 26939806 |
US |
2 | |
Brain fog, Pain in jaw, Gait disturbance, Headache, Nausea, Dizziness, Fatigue, Abdominal distension, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 96 | 26939924 |
US |
66 | 2 |
Hepatic failure, Hypophagia, Weight increased, Peripheral coldness, Hepatic cirrhosis, Fatigue, Joint swelling, Arthralgia, Asthenia, Ligament sprain, Gait disturbance, |
||||
THYROID, PORCINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, |
||||
| 97 | 26945562 |
2 | ||
Dizziness, Headache, Cough, Throat irritation, Pain in extremity, Myalgia, Pain in extremity, Gait disturbance, Fall, |
||||
SILDENAFIL CITRATE, SILDENAFIL, |
||||
| 98 | 26931373 |
US |
45 | 2 |
Gait disturbance, Vision blurred, Diplopia, Balance disorder, Vomiting, |
||||
TIRZEPATIDE, |
||||
| 99 | 26931476 |
CN |
15 | 2 |
Toxicity to various agents, Overdose, Dizziness, Feeling abnormal, Gait disturbance, Abdominal pain upper, Off label use, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 100 | 26931558 |
US |
1 | |
Dyspnoea, Dysuria, Constipation, Swelling face, Swollen tongue, Pharyngeal swelling, Cardiac disorder, Lung disorder, Renal impairment, Liver disorder, Gastrointestinal disorder, Urinary incontinence, Gait disturbance, Pain, Hypersensitivity, Neuropathy peripheral, Product contamination, Anxiety, Depression, Insomnia, |
||||
VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, VALSARTAN, VALSARTAN ORAL, LOSARTAN, LOSARTAN, LOSARTAN, LOSARTAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30